Literature DB >> 591130

Immunostimulation of chemical oncogenesis in the mouse.

R T Prehn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591130     DOI: 10.1002/ijc.2910200615

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors:  Z Chen; C W Smith; D Kiel; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

2.  A semiquantitative measure of immune responses against erythropoietic stem cell antigens.

Authors:  D E Harrison
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 3.  Tumor immunogenicity: how far can it be pushed?

Authors:  R T Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

4.  A chemical carcinogen, 3-methylcholanthrene, alters T-cell function and induces T-suppressor cells in a mouse model system.

Authors:  L J Alfred; A Wojdani; M Nieto; R Perez; G Yoshida
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

Review 5.  An immune reaction may be necessary for cancer development.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-02-03       Impact factor: 2.432

6.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

7.  On the nature of cancer and why anticancer vaccines don't work.

Authors:  Richmond T Prehn
Journal:  Cancer Cell Int       Date:  2005-08-01       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.